| ²é¿´: 233 | »Ø¸´: 2 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
[½»Á÷]
ÃÀ¹ú°©Ö¢Ñо¿Ñ§»á
|
|||
| ÃÀ¹ú°©Ö¢Ñо¿Ñ§»á |
» ²ÂÄãϲ»¶
Çó¹ºHIB-1Bϸ°û
ÒѾÓÐ2È˻ظ´
ÖÐɽ´óѧ¸½ÊôµÚ°ËÒ½Ôº-ÕŻ۶«ÍŶÓÕÐÊÕ2026¼¶±£ÑÐ˶ʿÑо¿Éú
ÒѾÓÐ15È˻ظ´
¿ÚÇ»Âò¢Ãæ¿ÆÑ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ131È˻ظ´
ÖÐɽ´óѧ¸½ÊôµÚ°ËÒ½Ôº-ÕŻ۶«ÍŶÓÕÐÊÕ2026¼¶ÍÆÃâÑо¿Éú
ÒѾÓÐ7È˻ظ´
À¼ÖÝ´óѧÕÐÊÕ2026¼¶Ë¶Ê¿Ñо¿Éú(ÖÐɽ´óѧÁªÅࣩ
ÒѾÓÐ6È˻ظ´
ΧÊÖÊõÆÚ¹ÜÀí£ºÂé×íר¼ÒÍøÂçÑÐÌÖϵÁлá
ÒѾÓÐ0È˻ظ´
ÖÐɽ´óѧ-À¼ÖÝ´óѧÁªºÏÕÐÊÕ2026¼¶²©Ê¿Ñо¿Éú
ÒѾÓÐ15È˻ظ´
ÖÐɽ´óѧ ÕŻ۶«ÍÅ¶Ó ³£ÄêÕÐÊÕ ²©Ê¿Ñо¿Éú
ÒѾÓÐ12È˻ظ´
ÖÐɽ´óѧ ÕŻ۶«ÍÅ¶Ó ³£ÄêÕÐÊÕ Ë¶Ê¿Ñо¿Éú
ÒѾÓÐ13È˻ظ´
|
American Association for Cancer Research ÃÀ¹ú°©Ö¢Ñо¿Ñ§»áAACRÊÇ·¢²¼Óйذ©Ö¢³ÉÒò¡¢Õï¶Ï¡¢ÖÎÁƺÍÔ¤·À½øÕ¹Çé¿öµÄȨÍþ×éÖ¯¡£AACRͨ¹ýÍÆ¶¯°©Ö¢ÐÂ֪ʶµÄÔö³¤ºÍ´«²¥¶øÕ¾Á¢ÓÚ·ÀÖΰ©Ö¢µÄǰÏß¡£AACRÊÇÊÀ½çÉϳÉÁ¢×îÔç¡¢¹æÄ£×î´óµÄÖÂÁ¦ÓÚÈ«Ãæ¡¢´´Ðº͸ßË®×¼°©Ö¢Ñо¿µÄ¿ÆÑ§×éÖ¯¡£Æä¿ÆÑз¶Î§¹ã·º¡¢³É¼¨×¿Öø£¬ÔÚÒµÄÚÏíÓÐÊ¢Ãû£¬ÎüÒýÁËÖÚ¶àµÄÑо¿Õß¡£AACRµÄ³ÌÐòºÍ·þÎñ´Ù½øÁ˰©Ö¢¿ÆÑ§¼ÒÃÇ֪ʶºÍ¹ÛÄîµÄ½»Á÷£¬ÎªÐÂÒ»´ú°©Ö¢Ñо¿ÈËÔ±ÌṩÁËÅàѵ»ú»á£¬Ò²Ôö½øÁ˹«ÖÚ¶Ô°©Ö¢µÄÁ˽⡣ 1. Cancer Epidemiology Biomarkers & Prevention (1055-9965)¡¶°©Á÷Ðв¡Ñ§£ºÉúÎï±ê¼ÇÓëÔ¤·À¡·×ÅÑÛÓÚȺÌå½Ç¶È£¬³¬³öÁ˶Ô΢ÉúÎϸ°ûÒÔ¼°¸öÌå·½Ãæ¶Ô°©Ö¢µÄÑо¿·¶Î§¡£¿¯Ôذ©Ö¢²¡ÒòºÍÔ¤·ÀµÄÑо¿ÂÛÎÄ£¬¸²¸ÇÁ˰©Ö¢Á÷Ðв¡Ñ§µÄËùÓз½Ã棬°üÀ¨·Ö×ӺͻùÒòÁ÷Ðв¡Ñ§£¬ÒÔ¼°»¯Ñ§Ô¤·À¡¢ÓªÑøÒÔ¼°ÐÐΪ±ä»¯µÈÔ¤·ÀÑо¿¡£ÔÚÖ×Áöѧ¿ÆÁìÓòÅÅÃûµÚ26룬2007ÄêIF£º4.642 2. Cancer Prevention Research (1940-6207)¡¶°©Ö¢Ô¤·ÀÑо¿¡·¿¯ÔØÓйØÁöÐγɡ¢·çÏÕÒòËØºÍÆÀ¹À¡¢ÔçÆÚɸ¼ìÑо¿ÒÔ¼°°©Ö¢Ô¤·ÀºÍ¸ÉÔ¤·½ÃæµÄÖØ´óÔ´´Ñо¿¡¢ÆÀÂÛ¼°¹Ûµã¡£ 3. Cancer Research (0008-5472)¡¶°©Ö¢Ñо¿¡·Êǵ±½ñÊÀ½çÉ϶԰©Ö¢Ñо¿×îÈ«ÃæµÄµÄÔÓÖ¾Ö®Ò»£¬ËüÊÇҽѧ½ç×î³£Óõݩ֢ÆÚ¿¯£¬½éÉÜÁËÔÚ°©Ö¢Ñо¿µÄËùÓÐÁìÓòÄÚ×îÇ°ÑØ¡¢×îȨÍþÒÔ¼°×îÖØÒªµÄÑо¿½á¹û£¬º¸ÇÁËʵÑéÊÒÑо¿µ½×ª»¯ÐÍÑо¿¡¢ÁÙ´²¡¢Á÷Ðв¡Ñ§ÒÔ¼°Ô¤·ÀµÈ¸÷¸ö°©Ö¢Ñо¿ÁìÓò¡£ÔÚÖ×Áöѧ¿ÆÁìÓòÅÅÃûµÚ8룬2007ÄêIF£º7.672 4. Clinical Cancer Research(1078-0432)ÁÙ´²°©Ö¢Ñо¿¡·ÊÇÃÀ¹ú°©Ö¢Ñо¿Ñ§»áÔÚʵÑéÊÒºÍÁÙ´²Ñо¿·½Ãæ²»¶ÏÓÐз¢ÏÖµÄѧÊõ½»Á÷ÆÚ¿¯£¬¿¯µÇ×îÕñ·ÜÈËÐĵÄת»¯ÐͺÍÁÙ´²Ñо¿³É¹û£¬°üÀ¨½×¶ÎIIºÍ½×¶ÎIIIµÄʵÑ鱨¸æ¡¢¡°ÉúÎïѧĻºó¡±ÏµÁС¢ÒÔ¼°À´×Ô·Ö×ÓÖ×Áöѧµ½ÉúÎïͳ¼ÆÑ§Ö÷ÌâµÄÂÛÎÄ¡£ÔÚÖ×Áöѧ¿ÆÁìÓòÅÅÃûµÚ15룬2007ÄêIF£º6.25 5. Molecular Cancer Research(1541-7786)¡¶·Ö×Ó°©Ö¢ÖÎÁÆÑ§¡·Éæ¼°ÁË»ù´¡ÊµÑéÊÒµÄ×îз¢ÏÖ£¬Îª°©Ö¢µÄÖÎÁÆ·½·¨´øÀ´Á˸üΪֱ½ÓÉîÔ¶µÄÓ°Ïì¡£·¢±íÁËÔÚ°©Ö¢ÔÀí·¶Î§ÄÚ²ûÊö·Ö×ӽṹ¡¢ÉúÎïÐÐΪºÍÒ©Àíѧ¼Á×÷ÓûúÀíÖ®¼ä¹ØÏµÑо¿µÄÂÛÎÄ¡£ÔÚÖ×Áöѧ¿ÆÁìÓòÅÅÃûµÚ36룬2007ÄêIF£º4.317 6. Molecular Cancer Therapeutics(1535-7163)¡¶·Ö×Ó°©Ö¢Ñо¿¡·×ÅÑÛÓÚ°©Ö¢·Ö×ÓºÍϸ°û·½ÃæµÄ×îÐÂÀíÂÛ£¬Îª°©Ö¢ÉúÎïѧºÍÖ×ÁöÉúÀíѧ´øÀ´ÁË×îй۵㣬Ϊ¹¥¿Ë°©Ö¢Ìṩ×î¾ßÓ°ÏìµÄÑо¿×ÊÔ´¡£ÔÚÖ×Áöѧ¿ÆÁìÓòÅÅÃûµÚ25룬2007ÄêIF£º4.8 ʹÓÃÖ¸ÄÏ£º µÇ¼http://www.aacrjournals.org/ä¯ÀÀÈ«ÎÄ£¬²»ÐèÒª¹ú¼ÊÁ÷Á¿·Ñ¡£ ²ÉÓÃIP¿ØÖÆ·ÃÎÊ£ºÖ±½ÓµÇÂ¼ÍøÕ¾ä¯ÀÀÈ«ÎÄ¡£ ²ÉÓÃÓû§Ãû+ÃÜÂ뷽ʽ£ºÓû§Ãûcwg2009£¬ÃÜÂëtrial2009 ÊÔÓÃÆÚÏÞ£º 2009Äê4ÔÂ1ÈÕÖÁ2009Äê6ÔÂ30ÈÕ Èç¹û²»ÄÜä¯ÀÀÈ«ÎÄ£¬ÇëÁªÏµ¹óУͼÊé¹Ý£¬»òÕß²é¶û˹ÎÖ˼¹«Ë¾£º µç»°£º£¨010£©67791621-101¡¢112¡¢135 ÐÅÏ䣺info@charlesworth.com.cn; sales@charlesworth.com.cn |
2Â¥2009-05-13 11:54:02
lxf3380
ʵϰ°æÖ÷
![]() ![]() |
3Â¥2009-05-16 00:19:00














»Ø¸´´ËÂ¥
